Companies continue to be drawn to the St. Louis ecosystem. In 2013, drug development company Tansna Therapeutics relocated from Iowa. Adarza Biosystems of Rochester, NY established its primary business, manufacturing, and product development activities in St. Louis. Canadian contract research organization Pharma Medica Research chose the St. Louis region as the location for its first U.S. facility.
Cortex Innovation District saw tremendous momentum this year highlighted by a $185 million Phase II centered around a new public park, Cortex Commons. Phase II comprises historic reuse and new construction, including the 200,000-sq.ft. BJC @ The Commons housing 1,000 employees. In November, iconic retailer IKEA announced it will add its presence to the 24/7 live - work district.
Momentum in St. Louis bioscience was accompanied in 2013 by a surge in entrepreneurial activity in other St. Louis technology sectors with new venture funds and accelerators, expanding incubators, and an exploding community of emerging startups. A recap can be found here.